Latest filing published 18 Aug 2026 for Tandem Diabetes Care INC. Read the official filing
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Jean-Claude Kyrillos, listed as senior executive, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Tandem Diabetes Care Inc and Envista Holdings Corp. We count 14 filings; the first trade dates from 25 February 2022 and the latest from 15 August 2026.
On the market, this insider has only ever bought: 1 purchase, €177k in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 7 share grants and 6 option exercises.
Most recently, on 18 August 2026, the filings show an option exercise in Tandem Diabetes Care Inc. The latest purchase dates back some time: it was published 586 days ago, on 11 March 2025. The median gap between a trade and its publication by SEC (Form 4) is 3 days. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
14 of 14 declarations